Collaborative investigation of variables in susceptibility testing of yeasts
Open Access
- 1 September 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (9) , 1648-1654
- https://doi.org/10.1128/aac.34.9.1648
Abstract
A multicenter study was performed to evaluate the effect of medium, incubation time (24 and 48 h), and temperature (30 and 35 degrees C) on intra- and interlaboratory variations in MICs of flucytosine, amphotericin B, and ketoconazole for yeasts. Testing was performed on coded isolates of Candida species (11 strains) and Cryptococcus neoformans (2 strains) by using a standard macrodilution protocol 11 laboratories. Four chemically defined media buffered to pH 7.0 with morpholinepropanesulfonic acid were evaluated, including buffered yeast nitrogen base, synthetic amino acid medium-fungal, RPMI 1640 medium, and high-resolution antifungal assay medium. Intralaboratory variability was less than or equal to fourfold for 97% of the replicate sets of data. The highest level of interlaboratory agreement, irrespective of antifungal agent or incubation conditions, was observed with RPMI 1640 medium. Intralaboratory variability was less than or equal to fourfold for 93% of the determinations with ketoconazole and 100% with flucytosine tested in RPMI 1640 medium at 35 degrees C for 24 h. Variability in amphotericin B results was less than or equal to fourfold for 81% of the determinations in RPMI 1640 medium at 35 degrees C for 48 h. The rank order of MICs within each antifungal test group was similar among the various laboratories and was generally in agreement with the reference rank order regardless of the test medium that we used.This publication has 25 references indexed in Scilit:
- Antifungal susceptibility testsAntimicrobial Agents and Chemotherapy, 1987
- In Vitro Antifungal Susceptibility Testing and Measurement of Levels of Antifungal Agents in Body FluidsClinical Infectious Diseases, 1987
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic mediaAntimicrobial Agents and Chemotherapy, 1984
- Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis ModelThe Journal of Infectious Diseases, 1983
- Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importanceJournal of Antimicrobial Chemotherapy, 1980
- Turbidimetric Studies of Growth Inhibition of Yeasts with Three Drugs: Inquiry into Inoculum-Dependent Susceptibility Testing, Time of Onset of Drug Effect, and Implications for Current and Newer MethodsAntimicrobial Agents and Chemotherapy, 1978
- Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum SizeAntimicrobial Agents and Chemotherapy, 1976
- Variables Influencing Susceptibility Testing of Cryptococcus neoformans to 5-FluorocytosineAntimicrobial Agents and Chemotherapy, 1973
- Fungistatic Activity, Uptake and Incorporation of 5-Fluorocytosine in Candida albicans, as Influenced by Pyrimidines and Purines. I. Reversal ExperimentsPathobiology, 1973